{"id":1302,"date":"2023-01-12T09:00:20","date_gmt":"2023-01-12T09:00:20","guid":{"rendered":"https:\/\/discovery-park.co.uk\/?p=1302"},"modified":"2023-08-29T11:51:41","modified_gmt":"2023-08-29T11:51:41","slug":"tackling-life-sciences-challenges-through-collaboration-in-2023","status":"publish","type":"post","link":"https:\/\/discovery-park.co.uk\/tackling-life-sciences-challenges-through-collaboration-in-2023\/","title":{"rendered":"Tackling Life Sciences Challenges Through Collaboration in 2023"},"content":{"rendered":"
The last 12 months have been challenging on every front, from Covid recovery and soaring energy prices to the slump in investment in Life Sciences, while the Government\u2019s decision on R&D tax credits has been the most recent blow to a sector whose huge potential is being thwarted by a shortage of lab space and a lack of funding.<\/p>\n
Ahead of the recent review, the\u00a0BIA<\/a>\u00a0urged the government to use a light hand when altering regimes as it believed that the then SME and large company R&D set ups worked well, and now in the light of the outcome it is continuing to review the implications of the changes.<\/p>\n Meanwhile, information shared at the\u00a0Genesis 2022 life sciences conference<\/a>\u00a0in London showed a fall-off in biologics innovation, a steep drop in IPO financing and described the Biopharma market as \u2018still in the dumps.\u2019<\/p>\n But waiting for these issues to be resolved is not an option. Science parks must continue to innovate in order to sustain future growth. We are on the brink of being a global force in life sciences and biotechnology and we can\u2019t let this opportunity slip away now.<\/p>\n So what can we do in 2023 that will bring our ambitions within reach? Well, we can start by collaborating.<\/p>\n By forging new links and making fresh connections we can build on our successes and overcome the obstacles in our path. It is only through pooling our knowledge and resources that we will be able to move research out of academia, into clinics and ultimately create effective treatments, to the benefit of patients, companies, science parks and the UK PLC.<\/p>\n At Discovery Park we describe ourselves as an \u2018ecosystem\u2019 and as a \u2018community thriving on collaboration\u2019. We provide facilities; access to business services and life sciences expertise; links with further and higher education; and we foster a network of tenants who are working collaboratively to achieve their goals; but that\u2019s not all, we also look to the wider life sciences and biotech communities in order to establish relationships that will benefit those involved.<\/p>\n We have recently opened our Incubation Hub \u2013 50,000 sq ft of wet labs and workspaces where start-ups can become established \u2013 and growing and supporting this community will be one of our major areas of focus in 2023.<\/p>\n Helping with this will be our new\u00a0Barclays Eagle Lab<\/a>, which is one of the largest co-working and incubator networks for start-ups and scale-ups in the UK, supporting entrepreneurs and ambitious businesses to collaborate, innovate and grow.<\/p>\n